Articles for author: Russ Cohen

Russ Cohen

Most Popular

The Leading Tech Stocks of May 2024 The Leading Tech Stocks of May 2024

Celestica: A Rising Star in Electronics Manufacturing The technology sector has been a hotbed of innovation and growth, attracting investors with its promise of future returns. One standout company in this realm is Celestica (NYSE:CLS), an electronics manufacturing firm that has seen its stock price skyrocket over the past year. ACM Research: Cleaning Up in ...

Russ Cohen

Most Popular

Sea Limited (SE) to Report Q1 Earnings: What's in Store?

Anticipating Sea Limited (SE) Q1 Earnings Report Sea Limited (SE) Q1 Earnings Preview Sea Limited (SE) is preparing to unveil its first-quarter 2024 financial results on May 14. The Zacks Consensus Estimate for earnings remains steady at 36 cents over the past month, indicating a 40.98% drop year over year. Revenue estimates sit at $3.62 ...

Russ Cohen

Most Popular

Understanding Perion Network’s Stock Decline

The Struggle Behind Perion’s Declining Stock Perion Network, a player in the adtech industry, witnessed a disheartening descent in its stock for two consecutive days. The plunge began after the company shared its first-quarter earnings report, initially resonating well with the market but took a nosedive later in the session. The nail in the coffin ...

Russ Cohen

Most Popular

Unveiling Allstate (ALL): Wall Street’s Bullish Views & Worthiness of Investment Unveiling Allstate (ALL): Wall Street’s Bullish Views & Worthiness of Investment

Before deciding on a stock investment, it’s common practice for investors to seek guidance from Wall Street analysts. The question lingers: are these analyst recommendations truly reliable indicators? Let’s delve into the realm of Allstate (ALL) and explore the current sentiments of Wall Street analysts alongside the real worth of their advice. Understanding Brokerage Recommendations ...

Russ Cohen

Most Popular

Deciphera Pharmaceuticals Earnings Report: A Closer Look at Q1 2024 Results Deciphera Pharmaceuticals Earnings Report: A Closer Look at Q1 2024 Results

Source: iQoncept / Shutterstock Deciphera Pharmaceuticals (NASDAQ:DCPH) recently unveiled its performance for the first quarter of 2024. Deciphera Pharmaceuticals exceeded expectations by reporting earnings per share of -52 cents, surpassing the analysts’ projected figure of -55 cents. The company recorded revenue amounting to $45.00 million. However, this fell short by 2.77% compared to the anticipated ...

Russ Cohen

Most Popular

Analyzing Alibaba Stock: A Deep Dive Deciphering Alibaba’s Future: An In-Depth Analysis

Alibaba Group (NYSE: BABA) has experienced a turbulent journey in recent times, witnessing a significant downturn of nearly 60% in the stock value over the past five years. Despite this challenging period, billionaire co-founder Jack Ma has expressed confidence in the company’s restructuring endeavors. Acknowledging past mistakes, Ma highlighted the strategic move to divide the ...

Russ Cohen

Most Popular

Insights into Promising Earnings Performers This Quarter Insights into Promising Earnings Performers This Quarter

Companies have generally managed to perform well against the consensus of earnings forecasts. In Q1, about 77% of S&P 500 firms are considered earnings outperformers. This rate surpasses the typical figure of 74% observed in the early months of the year, indicating a positive trend outstripping historical norms. Steering into AI’s Orbit The prevailing theme ...